Cargando…
Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global coronavirus disease 2019 (COVID-19) pandemic, causing a huge loss of human life and a negative impact on economic development. It is an urgent necessity to explore potential drugs against viruses, such as SAR...
Autores principales: | Zhang, Chunye, Sui, Yuxiang, Liu, Shuai, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610370/ https://www.ncbi.nlm.nih.gov/pubmed/37895950 http://dx.doi.org/10.3390/ph16101479 |
Ejemplares similares
-
In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches
por: Zhang, Chunye, et al.
Publicado: (2023) -
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
por: Vargas-Mendoza, Nancy, et al.
Publicado: (2020) -
Antiviral activity of silymarin and baicalein against dengue virus
por: Low, Zhao Xuan, et al.
Publicado: (2021) -
Molecules against Covid-19: An in silico approach for drug development
por: Bharti, Rhythm, et al.
Publicado: (2021) -
Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)